
EUROPEAN OPPORTUNITIES TRUST PLC
Legal Entity Identifier: 549300XN7RXQWHN18849
Month end portfolio information as at 31 March 2025
Total Net Assets: £ 566,609,583
Total Assets (including drawdown bank debt): £ 636,609,583
Top Twenty Holdings
Stock | Sector | Country of Listing | % of Total Assets (Incl Drawn down bank debt) |
Deutsche Boerse AG | Financials | Germany | 9.4 |
Relx Plc | Industrials | Netherlands | 7.6 |
Dassault Systemes SE | Information Technology | France | 7.4 |
Experian Plc | Industrials | United Kingdom | 7.3 |
Novo Nordisk A/S-B | Health Care | Denmark | 6.9 |
Genus Plc | Health Care | United Kingdom | 5.6 |
Intermediate Capital Group | Financials | United Kingdom | 5.2 |
Edenred | Financials | France | 4.6 |
Biomerieux | Health Care | France | 4.6 |
Gaztransport Et Technigaz SA | Energy | France | 4.1 |
Camurus AB | Health Care | Sweden | 4.0 |
Prysmian SPA | Industrials | Italy | 3.7 |
Grifols SA | Health Care | Spain | 3.4 |
Ryanair Holdings ADR | Industrials | Ireland | 3.0 |
Thales SA | Industrials | France | 2.0 |
Oxford Instruments Plc | Information Technology | United Kingdom | 2.4 |
BAE Systems Plc | Industrials | United Kingdom | 2.0 |
CTS Eventim Ag & Co KGAA | Communication Services | Germany | 1.7 |
Genmab A/S | Health Care | Denmark | 1.6 |
Country of listing of investee companies
Country | % of Total assets (including drawn down bank debt) |
France | 25.9 |
United Kingdom | 23.1 |
Germany | 14.7 |
Netherlands | 9.2 |
Denmark | 8.5 |
Italy | 4.7 |
Sweden | 4.4 |
Spain | 3.4 |
Ireland | 3.0 |
Switzerland | 0.8 |
Cash/(Gearing) | 2.3 |
Market Capitalisation of investee companies
Market Cap | % of Total Assets (including Drawn down bank debt) |
Large | 82.1 |
Mid | 15.6 |
Small | 0.0 |
Cash/(Gearing) | 2.3 |
The Company's most recent report and accounts and further information for shareholders is published on the Company's website at www.europeanopportunitiestrust.com
Enquiries:
Devon Equity Management Limited,
Company Secretaries to European Opportunities Trust PLC
Richard Pavry
020 3985 0441
08 April 2025
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.